Bridgeway Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $244K | Buy |
98,300
+25,200
| +34% | +$62.5K | 0.01% | 920 |
|
|
2025
Q1 | $113K | Sell |
73,100
-71,500
| -49% | -$111K | ﹤0.01% | 1015 |
|
|
2024
Q4 | $309K | Sell |
144,600
-4,600
| -3% | -$9.84K | 0.01% | 916 |
|
|
2024
Q3 | $649K | Sell |
149,200
-23,800
| -14% | -$104K | 0.01% | 800 |
|
|
2024
Q2 | $806K | Hold |
173,000
| – | – | 0.02% | 745 |
|
|
2024
Q1 | $877K | Sell |
173,000
-19,000
| -10% | -$96.3K | 0.02% | 776 |
|
|
2023
Q4 | $540K | Buy |
192,000
+65,500
| +52% | +$184K | 0.01% | 921 |
|
|
2023
Q3 | $363K | Buy |
126,500
+51,500
| +69% | +$148K | 0.01% | 969 |
|
|
2023
Q2 | $379K | Hold |
75,000
| – | – | 0.01% | 981 |
|
|
2023
Q1 | $142K | Sell |
75,000
-50,000
| -40% | -$94.5K | ﹤0.01% | 1169 |
|
|
2022
Q4 | $225K | Hold |
125,000
| – | – | 0.01% | 1062 |
|
|
2022
Q3 | $211K | Buy |
125,000
+59,800
| +92% | +$101K | 0.01% | 1130 |
|
|
2022
Q2 | $160K | Sell |
65,200
-12,000
| -16% | -$29.4K | ﹤0.01% | 1137 |
|
|
2022
Q1 | $214K | Buy |
+77,200
| New | +$214K | ﹤0.01% | 1160 |
|